Skip to main content
Back to shop

KLOW

80 mg

KPV + GHK-CuBPC-157 + TB-500Four-peptide blend

A lyophilized blend of BPC-157, TB-500, GHK-Cu and KPV for laboratory research. The component literature examines cell migration, extracellular matrix regulation and inflammatory signaling; it does not establish the effects of the combined blend.

Research use only. Not for human or veterinary use.

Strength

Quantity

1
Only 9 left in stock

Bundle & save

Buy more, save more - discounts apply automatically.

Total$52.99
Pay with

Batch documentation

Quality, documented

KLOW

0 published certificates

Looking for a batch report?

A certificate for KLOW is not currently published. Contact our team with the product name and batch number so we can help you find the relevant documentation.

Request documentation

Technical specifications

Compound information

Molecular profile

About KLOW

Type
Four-peptide research blend
CAS number
No single CAS number (blend)
Molecular weight
Mixture; no single molecular weight
Amino acids
BPC-157: 15; GHK-Cu: 3; KPV: 3; TB-500: form-dependent

This blend has no single PubChem record. TB-500 can refer to different thymosin beta-4 forms; confirm the component identity in batch documentation.

Storage requirements

Stability information

Avoid freeze/thaw cyclesProtect from light
Sealed vial · lyophilized
−20 °C for powder storage. Follow the instructions supplied with your batch.
Reconstituted temperature
2–8 °C. Follow the handling requirements for your formulation.
Shelf life analysis
No batch-specific stability analysis is published here. Refer to the label or batch documentation for expiry dating.

Reference storage conditions are not a shelf-life guarantee. Batch-specific instructions take precedence.

Literature & compound records

The research behind KLOW

Explore 3 research references and compound records. Expand a reference for its full citation and source.

  1. 01

    Gastroenterology · 2008

    PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

    Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. Gastroenterology. 2008;134(1):166-178. doi:10.1053/j.gastro.2007.10.026.

    Read source
  2. 02

    Current pharmaceutical design · 2018

    BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing

    Seiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH, Barisic I, Kokot A, Japjec M, Blagaic AB, Tvrdeic A, Rokotov DS, Vrcic H, Staresinic M, Sebecic B, Sikiric P. Current pharmaceutical design. 2018;24(18):1972-1989. doi:10.2174/1381612824666180712110447.

    Read source
  3. 03

    Molecules (Basel, Switzerland) · 2014

    Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts

    Chang CH, Tsai WC, Hsu YH, Pang JH. Molecules (Basel, Switzerland). 2014;19(11):19066-19077. doi:10.3390/molecules191119066.

    Read source

These references describe research materials, not testing of Pepvoro batches.

Related compounds